• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Good Practice for Introducing Radiopharmaceuticals for Clinical Use

IAEA TECDOC No. 1782
English IAEA-TECDOC-1782 978-92-0-111215-6
80 6 18.00 2015

Download PDF (3.96 MB)

Description

The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases — information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to facilitate and expedite the introduction of radiopharmaceuticals already in clinical use in other countries. This publication intends to provide practical support for the introduction of new radiotracers, including recommendations on the necessary steps needed to facilitate and expedite the introduction of radiopharmaceuticals in clinical use, while ensuring that a safe and high quality product is administered to the patient at all times.

More Information on reusing IAEA copyright material.

Keywords

Nuclear Medicine, Radiopharmaceuticals, Radioisotopes in Medical Diagnosis, Radiotracers, Health, Quality Control, Good Practice, Clinical Use, Recommendations, Cancer, Member States, Heart Diseases, Patients

How to order

Ordering Locally

Please use the following links for an up-to-date list of IAEA distributors:

Distributors of IAEA Publications


Orders and requests for information may also be addressed to:

Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria

Tel.: +43 1 2600 22529, +43 1 2600 22530
Fax: +43 1 2600 29302
Email: sales.publications@iaea.org


Download order form

Resources

  1. Employment
  2. Women
  3. Press

Stay in touch

Newsletter